THE EXPRESSION OF THE RARE CAVEOLIN-3 VARIANT T78M ALTERS CARDIAC ION CHANNELS FUNCTION AND MEMBRANE EXCITABILITY. by M. Bonzanni
1 
 
 
 
 
 
UNIVERSITA’ DEGLI STUDI DI MILANO 
 
PhD Course, XXX Cycle 
Ricerca Biomedica Integrata 
 
 
 
The expression of the rare caveolin-3 variant T78M alters 
cardiac ion channels function and membrane excitability. 
 
 
 
Tutor: Prof. Di Francesco Dario 
Coordinator: Prof.ssa Sforza Chiarella 
                                                                                     
                                                      
                Bonzanni Mattia  
                                                                            Matr. R10851                                          
 
2 
 
 
 
 
 
 
 
 
 
 
‘Electrophysiologists never die, they only depolarize.’  
Silvio Weidmann                                                                                                             
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PREFACE 
The identification of new molecular insights always drove the research. Data from genetic, 
molecular biology and biochemistry suggest new directions, open new fields and lead to new 
discoveries. The significance of these data is, in certain situation, difficult to envision. In this 
view, physiology could represent a reasonable read-out of the overall complex modifications 
inside the cell. In particular, electrophysiological analysis could shed light on both 
physiological and pathological conditions in excitable cells, where ion channels, cellular 
microenvironment, transcription factors and accessory proteins shape the electric profile. In 
my PhD, I mainly used this approach to test the effect of mutations found in patients affected 
by arrhythmic disorders (cardiac arrhythmia and epilepsy) and of exercise training on the 
electrical activity in the heart. In particular, I performed the following projects:  
- Electrophysiological characterization of the biophysical properties of the hHCN1 
L157V mutation found in a patient affected by idiopathic generalized epilepsy. A 
genetic panel testing more than 150 genes previously associated with the epileptic 
phenotype, failed to detect any other mutation over the L157V HCN1. I tested the 
effect of this mutation in a heterologous cell system (CHO cells) as well as in a simple 
neuronal environment, the neonatal rat cortical cells. In both cellular systems, the 
mutation affects the current density (-50% and -80% in CHO and neurons, 
respectively) in a dominant way over the WT isoform. The loss-of-function of the 
HCN1 current induced, in vitro, an increased excitability in cortical neurons, pointing 
out that the L157V could establish a susceptible environment more prone to 
epileptogenic events.  
- Analysis of the miRNA profile in response to chronic endurance training. I found that, 
in a mouse model of endurance training, the cardiac miRNA profile was affected in a 
regional-dependent manner. Moreover, some of these miRNAs were able to modulate 
the spontaneous firing rate of neonatal rat ventricular myocytes similarly to the 
modification found in the single cell isolated from the pacemaker region in trained 
mice. It is important to mention, moreover, that the cardiac levels of miR-1 and miR-
499a, muscle specific miRNAs modulated in the mouse model of training and able to 
affects the firing rate, correlate with their circulating levels and were modified in the 
plasma of human ultra-endurance athletes as well, suggesting a potential conserved 
pathway.  
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- Characterization of the impact of the T78M cav-3 variant found in a cohort of 
arrhythmic patients. This variant induces modification of several ionic currents 
leading to a pro-arrhythmogenic profile. This project is described in the present work.  
In the present study, I describe the project concerning the analysis of the T78M cav-3 variant. 
This variant has been previously associated with cardiac and skeletal disorders, but recently 
its role in the onset of arrhythmic diseases was questioned. A better understanding of the 
molecular effect of this variant could be helpful to settle its impact in a cardiac context. For 
this reason, I decided to present this work as my PhD thesis since these data could re-open 
the discussion on this variant and better define its impact in these life-threatening conditions. 
The leitmotiv of these projects is the identification of the causes underlying the 
pathophysiological modification of excitable cells; they clearly showed that ion channels, 
membrane proteins and post-transcriptional factors are key player in defining the electrical 
environment of a cell.  
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INTRODUCTION 
The multiple faces of caveolae.  
Signaling activity of biomembranes strictly depends on geometric parameters such as surface 
area and curvature; alongside the shape of the membrane, the inhomogeneity of this curvature 
is critical in defining protein association and hence signaling1. In many cell types, specialized 
highly hydrophobic plasma membrane subdomains known as caveolae play a key role in 
several cellular processes. These structures are small clathrin-free omega-shaped (50-100 nm) 
invaginations of the plasma membrane highly enriched in sphingolipids and cholesterol2. 
However, the definition of caveolae has been expanded to also include vesicles detached from 
the plasma membrane, associated in group as grasp-like clusters or rosettes3. It is important 
to note that, even if caveolae shares common aspect with lipid rafts (planar rafts with high 
cholesterol and sphingolipids content) such as the main lipid composition, they are distinct 
structures. In fact, it has been reported that several proteins resides specifically either in lipid 
rafts or in caveolae3. In particular, the localization of the caveolin proteins into caveolae 
distinguished them from lipid rafts. Indeed, caveolins are specific markers of the caveolar 
structure.  
 
Figure.  1 Caveolin structure from Patel et al., 2008 
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Molecular cloning has identified three different isoforms of caveolin (cav): cav-1, cav-2 and 
cav-3. They are 18-24 kDa proteins characterized by a “hairpin-like” topology (Fig. 1) with 
an N-terminal cytoplasmic domain containing the so called “scaffold domain”, which is 
crucial in the protein-protein interactions4. The sequences of cav-1 and cav-3 share a high 
degree of identity, whereas cav-2 is the most divergent isoform5. Despite this deviation, cav-2 
is detected selectively in cav-1 expressing cells. Indeed, cav-1 and -2 act in concert and they 
are most abundantly expressed in adipocytes, endothelial cells, type I pneumocytes and 
fibroblastic cell types, whereas the expression of cav-3 is considered muscle-specific (smooth, 
skeletal and cardiac muscles). This peculiar differential cellular distribution points out that 
cav-1 and -3 proteins, in spite of their high degree of identity, might possess distinct functions. 
Importantly, the ablation of both cav-1 and cav-3 is sufficient to inhibit the formation of 
caveolae, confirming their role as essential constituents in the biogenesis of caveolar 
domains6. Together with caveolin, the members of the cavin protein family (cavin-1, -2, -3 
and -4) aid in the generation of mature caveolae fostering the oligomerization of caveolin 
proteins. Cavins are cytoplasmic proteins with amino-terminal coiled-coil domains that form 
large heteromeric complexes and assist caveolin in the curvature of the plasma membrane. 
The predisposition of caveolin proteins to form oligomers, as well as the presence of 
cholesterol, are essential contributing factor to the formation of the caveolar domains. Indeed, 
caveolae synthesis is a complex, stepwise assembly process which requires several distinct 
molecules7(Figure 2). Caveolins are synthetized in the endoplasmic reticulum and rapidly 
undergoes the first stage of oligomerization generating oligomers formed by 7 to 14 caveolin 
monomers (8S-cav). After the exportation of these oligomers from the endoplasmic reticulum 
to the Golgi complex, cholesterol crystalized and assist to the 70S-caveolin oligomers 
formation combining 18-25 8S-cav structures. Indeed, cholesterol plays a critical role in the 
biogenesis, integrity and function of caveolae; in fact, its depletion leads to the disruption of 
the mature caveolar structure and prevent their genesis. Prior the insertion of the mature 
caveolar structure in the plasma membrane, both palmytoilation and cavin insertion processes 
are performed.  
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Figure.  2 Genesis of the caveolar mature domains from Busija et al., 2017 
Interactions between caveolins, cavins, lipids, and other proteins create an unique protein, 
lipid, and lipoprotein cellular microenvironment. Indeed, caveolae is an attractive way to 
segregate or integrate certain pathways in microdomains of the plasma membrane. Moreover, 
caveolae has been implicated in several physiological processes behind membrane trafficking 
and compartmentalization. For example, despite they were initially identified as almost static 
structure, caveolae participate in cell transport events such as endocytosis, transcytosis and 
pinocytosis2. Moreover, caveolar structures play a critical role not only as a transducer of the 
mechanical stimuli into chemical ones, but also participate in the cell migration processes. 
This modulation of the cytoskeleton is a consequence of the association between caveolae 
and several components of the cytoskeletal apparatus such as actin filaments, microtubules 
and intermediate filaments5. It is also important to mention that they have an important role 
in the homeostasis of cholesterol in the cell. Mainly, the influence of caveolae has been 
characterized extensively in signaling transduction processes; this is referred to as the 
“caveolae signaling hypothesis”.  
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The protein residing in the caveolar structure could bind directly the caveolin proteins thanks 
to the presence of a region known as caveolin binding domain (CBD).  This region recognizes 
the so-called caveolin scaffolding domain (CSD) on the caveolin proteins, in particular cav-1 
and cav-3. Caveolae, indeed, appeared to serve as signaling platforms for several different 
proteins, from signaling molecules, to receptors and ion channels. For example, caveolae 
generated by cav-1 compartmentalize G-protein subunits, receptor and non-receptor tyrosine 
kinases, endothelial nitric oxide synthase (eNOS), and small GTPases, while in the caveolae 
generated by cav-3 were found β-adrenergic receptors, protein kinase C isoforms, G proteins, 
Src-family kinases, multiple components of the dystrophin-glycoprotein complex and many 
ion channels8.  
Much insight into caveolar function has been gained thanks to the generation of caveolin null 
mice. Interestingly, the absence of caveolae in cav-1, cav-3 and double cav-1/3 KO mice did 
not lead to developmental abnormality nor lethality9. In particular, cav-1 KO mice had an 
increased cell proliferation, suggesting a tumor suppressor activity of cav-1. Moreover, cav-1 
KO mice develops cardiac hypertrophy. The absence of cav-3, on the other hand, leads to 
mild degenerative processes in the skeletal muscles without affecting the dystrophin-
associated complex and promote the development of a progressive cardiomyopathy10. 
Furthermore, both dihydropyridine receptor-1 α and ryanodine receptor were mislocalized in 
the T tubules, suggesting a pivotal role of cav-3 isoform in the proper assembly of this 
structure. The double cav-1/cav-3 KO mouse 11 develops severe cardiomyopathy promoted 
by a dramatic increase in left ventricular thickness with a significant decrease in fractional 
shortening. Moreover, histological analysis of Cav-1/3 double KO hearts revealed also 
disorganization and degeneration of the cardiac myocytes, as well as chronic interstitial 
fibrosis and inflammation. Despite many signaling processes are blunted and cardiac defects 
are reported in all KO mice models, compensatory mechanisms seems to counterbalance the 
absence of the caveolae structures in these transgenic mice.  
Ion channels residing in caveolae. 
Among proteins residing in caveolae, different subtypes of ion channels are present. Ion 
channels are a large family of molecules that are influenced by the subcellular 
microenvironment set by the caveolae. Indeed, a critical factor for understanding the 
regulation of ion channels is their precise subcellular localization, which is instrumental in 
the regulation of the underlying currents12. Ion channels are transmembrane proteins that 
conduct ionic currents across the plasma membrane. In excitable cells, they play a key in the 
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modification of the transmembrane potential and their activity is fundamental in the 
generation of membrane excitability in many cell subtypes.  The peculiar lipid environment 
present in the caveolae can directly affect the biophysical properties of ion channels; similarly, 
the compartmentalization of the signaling molecules able to specific regulate ion channel 
activity determines a highly localized control of ionic currents. Furthermore, the ability of 
caveolae to traffic the proteins to the plasma membrane regulates the availability of ion 
channels, and thus the current density12.  
Voltage-gated sodium channel. 
The voltage-gated sodium channel Nav1.5, encoded by SCN5A, was one of the first channels 
detected in caveolae. This channel is responsible for the initial upstroke phase of the action 
potential of both atria and ventricles and contributes to propagation of electrical impulses in 
the heart. The characteristics of INa current are influenced by the presence of β-
adrenoreceptors (βAR) in caveolae. In particular, βAR stimulation induced an increase in 
current amplitude through a PKA-dependent phosphorylation of the channel and by direct 
Gαs modulation
12.   
 L-type calcium channel.  
L-type calcium channels Cav1.2 (CACNA1C) are voltage-gated channels critical for the influx 
of Ca2+ able to trigger excitation-contraction coupling and they contribute to the plateau phase 
in myocytes of the working myocardium. In adult mammalian ventricular myocytes, L-type 
channels have been localized to both surface and T-tubular sarcolemma. Moreover, they are 
the major contributors of the upstroke phase in sinoatrial node cells. Some, but not all, Cav1.2 
resides in the caveolae13. Most importantly, various proteins involved in the cAMP/PKA 
signaling (i.e. β2 ARs, AC5/6, Gs, Gi, PP2A, and the type II R subunit of PKA), which are 
able to influence ICaL, reside in the caveolae
14 and many of these have been tied to Cav1.2 
through protein-protein interaction13. Functionally, the chemical depletion of cholesterol, 
which disrupts caveolae, led to an enhancement of the L-type calcium current because of the 
disruption of the inhibitory effect exerted by cav-3 on both β2-AR and adenylyl cyclase 
activity15. These results indicate that the caveolar domain is relevant in the proper 
maintenance of the β-AR-dependent modulation of Cav1.2 channels without affecting 
calcium current density.  
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Potassium channels 
In cardiomyocytes, several potassium channels are present and divided in voltage-gated (Kv) 
and inward rectifier (Kir) channels with peculiar cardiac sub-localization and unique gating 
properties. The Kv family includes Ito, IKur, IKr, and IKs, whereas IK1, IKACh, and IKATP belongs to 
the Kir family. The main tasks of potassium channels are to maintain the resting membrane 
potential (in working myocardium cells) and to repolarize the cell during the action potential. 
Some potassium channels are localized out of the caveolar domains, such as Kv11.1 (IKr ), 
while Kv1.5 (IKur), Kir2.1 (IK1) and Kir6.2 (IKATP) have been specifically identified in the 
caveolae. Kv11.1, even if is present in low-density membrane fractions, does not co-
immunoprecipitate with cav-316. Nevertheless, this channel is sensible to cholesterol 
depletion, indicating a connection between lipid composition and the channel activity. The 
Kv1.5 channel is responsible for the ultrarapid component of the delayed rectifier potassium 
current, the IKur. The channels possess also an inactivation state and they are involved in the 
initial phase of the repolarization of the atrial action potential. Despite the localization of 
Kv1.5 channels is under debate
12, Kv1.5 seems to reside in both caveolar and non-caveolar 
domains. However, McEwen et al17 clearly demonstrated that cav-3 is able to recruit Kv1.5 
channels from non-raft regions thanks to the formation of a tripartite complex with SAP9718. 
Moreover, the caveolar localization of the Kv1.5 channels affects the gating properties of the 
channel. Indeed, the disruption of caveolae led to a modification of the kinetic parameters of 
IKur in the HEK cellular system
19.  
 Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels.  
HCN channels conducts a mixed cationic inward current called funny current (If), which is 
one of the main current that contribute to cardiac automaticity in the sinoatrial node, the 
pacemaker region of the heart20. HCN channels are activated upon hyperpolarization of the 
membrane21 as well as in response to the binding of cyclic nucleotide such as cAMP22. Among 
the four isoforms of HCN channels (HCN-1, -2, -3 and -4), HCN4 is the main one expressed 
in nodal cells. HCN4 were demonstrated not only to specifically localize in the low density 
membrane fractions, but also to be functionally influenced by cav-3. The disruption of 
caveolar domain induced a rightward shift of the activation curve of HCN4; in addition, the 
depletion of cholesterol alters the channel kinetics23. The shift of the activation curve to more 
depolarized potentials after the disruption of the caveolae determined a faster firing rate of 
spontaneous action potentials in sinoatrial node cells. Furthermore, the caveolar integrity is 
crucial in the β2-AR-dependent modulation of the f-channels, and hence firing rate in the 
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sinoatrial node24. The critical modulation of HCN4 by caveolae is a consequence of the direct 
binding of this channel to cav-3. Indeed, a caveolin-binding motif is present in the sequence 
of the HCN4 channel, and the disruption of this binding domain led to an accumulation of 
the channel in the Golgi complex, indicating a close relation between the ability of HCN4 to 
bind cav-3 and its proper translocation to the membrane25.  
Caveolinopathies.  
Caveolinopathies are a heterogeneous group of muscle diseases that arise from mutation in 
the CAV3. Indeed, CAV3 is the only gene known to cause caveolinopathies26. A clear 
genotype-phenotype correlation cannot be traced in such pathology and both skeletal muscle 
and cardiac defects were associated with CAV3 mutations27, as visible in Figure 3, in which 
the same mutation was detected in patients affected by different phenotypes. Most of the 
caveolinopathies are inherited in heterozygosis with an autosomal-dominant inheritance, and 
only few autosomal recessive CAV3 mutations were reported. To date, the skeletal muscle 
phenotypes associated with CAV3 mutations are: limb girdle muscular dystrophy 1-C 
(LGMD), HyperCKemia (HCK), rippling muscle disease (RMD) and distal myopathy (DM). 
Together with the skeletal muscle phenotype, also cardiac defects were associated with CAV3 
mutations, even if the cardiologic component is less frequent or underdiagnosed. In 
particular, were reported patients carrying CAV3 mutations and affected by familial 
hypertrophic myopathy (FHM), Long-QT syndrome (LQTS) and some cases of sudden infant 
death syndrome (SIDS)28.  
 
Figure.  3 Hedley et al., 2013 
Caveolinopathies could be considered as a “clinical continuum”, since many patients showed 
an overlap of several skeletal muscle phenotypes. Among the CAV3 mutations identified until 
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now, T78M was the most common substitution 27-29 and it has been associated with both 
skeletal and cardiac diseases.  
T78M cav-3: a variant or a mutation? 
The 233C >T variant introduce the substitution of a methionine in place of a threonine in 
position 78 (T78M) of the cav-3 protein. It has been identified in patients with RMD, 
proximal myopathy, LQTS, idiopathic hyperCKemia, and SIDS28,30-32. A single patient 
homozygous for the T78M cav-3 was reported and he was affected by dilated 
cardiomyopathy, hyperCKemia and proximal myotonia33. The localization of T78M cav-3 
was controversial. Indeed, in COS-7 cells transfected with either the WT or T78M cav-3, both 
isoforms reached the plasma membrane33; in contrast, muscle biopsies of T78M cav-3 patients 
revealed a faint plasma membrane localization 32. Behind the identification of the T78M cav-
3 in the above-mentioned spectrum of diseases, few studies reported also the impact of the 
mutation on the ionic channel activity, hence providing evidence of functional alterations 
induced by the mutated cav-3. Cronk and colleagues31 found V14L, T78M and L79R cav-3 in 
a cohort of sudden infant deaths and T78M in 3 cases of LQTS over 1000 control alleles. 
They discovered that the co-expression of the T78M cav-3 with Nav1.5 in HEK cells induced 
a persistent late-sodium current (late INa), which generates a “gain-of-function” of the INa 
compatible with the LQTS clinical phenotype (characterized by a prolonged QT interval on 
the electrocardiogram and sudden cardiac death secondary to cardiac arrhythmias). 
Vaidyanathan and colleagues34 then demonstrated that T78M cav-3 is also able to 
significantly reduced the IK1 current in HEK cells. The loss of IK1 current, which is important 
in the proper maintenance of the resting membrane potential as well as in the repolarization 
of the action potential, was previously associated with different types of LQTS. These in vitro 
results, even if performed overexpressing the proteins in a heterologous cellular system, point 
out to a pro-arrhythmogenic role of T78M cav-3. Lately, however, genetic analysis questioned 
the potential pathogenic role of the T78M cav-3. In particular, Refsgaard et al 35 and 
Andreasen and colleagues 36  identified the T78M cav-3 in healthy controls and in a cohort of 
patients affected by LQTS or in case of SIDS with a similar prevalence, accordingly to the 
data from the Exon Sequencing Project. In agreement, Spadafora et al37 reported the T78M 
cav-3 as a common polymorphism in South Italy. To date, the literature on the T78M cav-3 
has neither clarified the impact of this mutation on membrane excitability, nor its role in the 
insurgence of arrhythmic diseases.  
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AIM OF THE WORK 
Arrhythmias are the most common electrical disturbances of the heart. Even if the etiology is 
complex and multifactorial, many genetic loci are associated with the insurgence of 
arrhythmic diseases. The microenvironment is able to shape and coordinate electric 
phenomena, and structural proteins such as caveolin are well-recognized modulators of ion 
channel activity. Mutations on CAV3 were identified in patients affected by both skeletal and 
cardiac pathologies, and among them, the most common variant is the T78M cav-3. In 
literature, the effect of the T78M variant remains unresolved and its pathogenic role is under 
debate; some in vitro studies suggest a pro-arrhythmogenic behaviour induced by T78M cav-
3, whereas genetic studies argued against its causative effect in cardiac dysfunctions. 
Considering that many cardiac arrhythmias may remain asymptomatic until the first cardiac 
event, it is relevant to shed light on mutations that could predispose, in association with aging, 
lifestyle and prior diseases, to the onset of cardiac electrical disturbances. This knowledge will 
be instrumental not only to enlighten the behavior of the ionic currents, but also in defining 
new clinical interventions.  
The aim of the work is to investigate the impact of T78M cav-3 on the overall cell excitability, 
focusing also on the role of this variant on the IKv1.5 and IHCN4 currents.  
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MATERIALS AND METHODS 
Cell culture and transfection. 
Mouse embryonic fibroblasts from caveolin-1 knock-out mice (MEF-KO)(3T3 MEF-KO 
CRL-2753TM, ATCC) were maintained in DMEM (Life Technologies), supplemented with 
10% FBS (Life Technologies) and 1% Penicillin-Streptomycin (Pen-Strep) (Sigma-Aldrich®). 
All animal procedures were in accordance with the Italian and UE laws (D. Lgs n°2014/26, 
2010/63/UE) and approved by the committee of the Università degli Studi di Milano and by 
the Italian Minister of Health (protocol number 1197/2015). Neonatal rat pups (Sprague 
Dawley, ENVIGO) were euthanized by cervical dislocation followed by decapitation. Hearts 
were quickly removed and ventricles were minced in small pieces in PBS and enzymatically 
digested (from 5 to 8 digestions) by gentle shaking at 37°C in ADS solution (in mmol/L: 116.4 
NaCl, 5.4 KCl, 1 NaH2PO4·H2O, 0.8 MgSO4·H2O, 5.5 glucose, 20 HEPES, pH 7.4) 
supplemented with collagenase I (136.8 U/ml, Whorthington) and pancreatine (0.6 mg/ml, 
Sigma). Neonatal rat ventricular cardiomyocytes (NRVCs) were then maintained in 
DMEM/M199 (Sigma), added with 10% Horse Serum (Euroclone), 5% FBS (Life 
Technologies), L-glutamine 2mmol/L and 1% Pen-Strep (Sigma-Aldrich®) at 37°C in a 5% 
CO2 incubator. The 233C>T substitution was inserted in the wild type (WT) cav-3 sequence 
subcloned into the pEGFP-N1 vector using the following primers: forward (5'-
cgtctgttgtccatgctgctgggcgt-3'), reverse (5'-acgcccagcagcatggacaacagacgg-3'). In pEGFP-N1 
vector, the protein of interest is fused to the eGFP. pCDNA 3.1 plasmids containing the 
sequence of hKv1.5 (with a V5-flag), hKir2.1 and hHCN4 were used for transfection. For 
both electrophysiological recordings and sucrose gradient fractionation experiments, MEF-
KO cells were plated on 35 mm dishes and co-transfected with 1.5 g of either the WT or 
T78M cav-3, or with 0.75 g of both, and 1 g of a plasmid containing the ion channel 
sequence (hHCN4, hKv1.5, hKir2.1) with Fugene HD or ViaFectTM Transfection Reagent 
(Promega). For electron microscopy experiments, MEF-KO cells were plated on 100 mm 
dishes and transfected with 13.5 g/dish of either the WT or T78M cav-3. NRVCs were 
transfected the day after isolation with either the WT or T78M plasmids (1.5 g). For 
membrane staining, MEF-KO cells were co-transfected with also a mix of the pECFP-Mem 
plasmid (Clontech), that target the protein to lipid rafts, and the pECFP-C1 
plasmid(Clontech), that target the proteins to non-rafts membranes.  
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Immunofluorescence analysis. 
48 hours after transfection, immunofluorescence analysis were carried out on living cells 
transfected with either the WT or T78M cav-3-EGFP and membrane CFP; images were 
acquired using a laser confocal microscope (Zeiss LSM710). 
Electron Microscopy experiments. 
For electron microscopy experiments, GFP-positive cells were sorted using flow cytometry 
(FACS Aria). Two hours after cell sorting, fluorescent cells were fixed as a monolayer in 2% 
glutaraldehyde in cacodylate buffer 0.1 mol/L (pH 7.4) for 20 minutes at room temperature, 
scraped and pelleted; cell pellets were further fixed for 24 hours at 4°C. Pellets were post-fixed 
in 2% osmium tetroxide in cacodylate buffer for 1 hour at room temperature, washed with 
the buffer, and en bloc stained with 1% uranyl acetate in distilled water for 45 minutes. Samples 
were then dehydrated in increasing ethanol series (70%, 80%, 90%, 100%, and propylene 
oxide for 10 minutes), and embedded in Epon resin, that was baked at 60°C for 48 hours. 
Thin sections were obtained with a Leica UC7 ultramicrotome (Leica Microsystems, Vienna, 
Austria), collected on 300 mesh copper grids, and stained with uranyl acetate and lead citrate. 
Sections were observed with a Philips CM10 transmission electron microscope (FEI, 
Eindhoven - Netherlands) at 80 kV. Images were acquired at a final magnification of 25000–
92000x using a Morada CCD camera (Olympus, Munster - Germany). All reagents were from 
Electron Microscopy Science (Hatfield PA). 
Separation of membrane fractions.  
Transfected MEF-KO cells were lysed in sodium carbonate (pH 11), homogenized with both 
a loose-fitting tissue homogenizer and a tip sonicator, and then centrifuged. The total protein 
content of the supernatant was measured with Pierce BCA Protein Assay Kit (Thermo 
Fisher). 8 mg of total proteins were placed in the bottom of an ultracentrifuge tube in 40% 
sucrose solution (in 25 mM Mes, 0.15M NaCl, pH 6.5), subsequently covered by 
discontinuous 35% and 5% sucrose solutions, and centrifuged at 38 000 rpm for 16 hours in 
a SW40 rotor ultracentrifuge (Beckmann). 12 mL-fractions were collected and divided as 
follows: fraction 1-3 were discarded; fractions 4-7 were pulled together and represent the 
cholesterol-enriched fraction (lipid rafts); fractions 8-12 were pulled together and represent 
the high density fraction (non-lipid raft). Proteins were precipitated for 30 min on ice in 7.92 
% trichloroacetic acid. After centrifugation and washing with ethyl ether, pellets were 
suspended in sample buffer for subsequent western blot analysis. 
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Co-immunoprecipitation and western blot. 
Co-IP buffer used to homogenized MEF-KO cells contained (in mmol/L): 10 Tris, 150 NaCl, 
60 octyl-β-D-glucopyranoside, 1% Triton X-100, pH 8 and EDTA-free protease inhibitor 
cocktail. Samples were centrifuged for 15 min at 10 000 x g at 4°C, and supernatants were 
immunoprecipitated overnight at 4°C, using 4 µg of the anti-cav-3 antibody (Ab) (Becton 
Dickinson). As negative controls we either omitted the anti-cav-3 antibody during the 
immunoprecipitation (IP) or the IP was carried out with the anti-cav-3 Ab on homogenized 
of MEF-KO cells transfected with channels but not with cav-3 (data not shown). 60 µl of anti-
mouse Dynabeads® (Life Technologies) were added and after 2 hours (4°C) the bound 
protein complexes were eluted in 45 µl of 3X NuPAGE LDS Sample Buffer (Life 
Technologies) and denaturated at 95°C for 5 min. An aliquot of the clarified lysates used for 
the immunoprecipitation (input) was run with the eluates on SDS-PAGE with NuPAGE Bis-
Tris 4-12% gels (Life Technologies), and revealed by western blotting. For western blotting, 
anti-cav-3 antibody (1:500), anti-V5 TAG antibody (Sigma-Aldrich; 1:1000) and anti-HCN4 
antibodies (Alomone Labs; 1:300) were used. HRP-conjugated and anti-mouse IgG (for anti-
cav-3) or anti-rabbit IgG (for anti-HCN4 and anti-V5) secondary antibodies were used.  The 
SuperSignal™ West Femto Maximum Sensitivity Substrate (Life Technologies) was used for 
the chemioluminescence detection. At the end of the whole procedure, the PVDF membranes 
were always stained with the amido black staining procedure to assess the efficiency of protein 
transfer. 
Electrophysiology and data analysis. 
Cells were superfused with and currents were recorded in Tyrode solution containing 
(mmol/L): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5.5 D-glucose, 5 Hepes-NaOH; pH 7.4. 
To dissect IHCN4 current in cardiomyocytes, 1 mmol/L BaCl2 and 2 mmol/L MnCl2 were 
added to the Tyrode solution. In order to magnify the IHCN4, in MEF-KO cells, the current 
was recorded using an extracellular solution containing (mmol/L): 110 NaCl, 0.5 MgCl2, 1.8 
CaCl2, 5 Hepes-NaOH, 30 KCl, pH 7.4. Patch-clamp pipettes had a resistance of 5-7 MΩ 
when filled with the intracellular-like solution containing (mmol/L): 130 KCl, 10 NaCl, 5 
EGTA-KOH, 0.5 MgCl2, 2 ATP (disodium-salt), 5 creatine phosphate, 0.1 GTP, 10 Hepes-
KOH; pH 7.2. In a set of experiments, a saturating concentration of of cAMP (10 µM) was 
added to the intracellular solution. 
hKv1.5 activation curves were obtained from tail currents at -40 mV after activating the 
current by 200 ms depolarizing steps in the range -60/80 mV applying +10 mV increments. 
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Inactivation curves were obtained from tail currents at +50 mV after current activation by 10 
s depolarizing test steps to the range -60/80 mV. Holding potential (hp) was set at -80 mV. 
hHCN4 and If activation curves were obtained from tail currents at -125 mV preceded by test 
steps in the range -35/-115 mV in -10 mV steps (hp at -30 mV). Activation and inactivation 
curves were fitted with the Boltzmann equation:  
y=1/(1+exp((V-V1/2)/s)) 
where V is voltage, y the fractional activation, V1/2 the half-activation voltage or the half-
inactivation voltage, and s the inverse-slope factor. hHCN4 activation time constants were 
obtained by fitting the current traces obtained from the activation protocol using a mono-
exponential function. Deactivation time constants were similarly obtained by fitting 
deactivating current traces recorded in the range -65/+25 mV after a fully activating voltage 
step at -125 mV.  
For current density analysis, current intensity at each potential was normalized by cell 
capacitance. hKir2.1 current was analyzed as the Ba2+-sensitive component elicited by 10 mV 
voltage steps in the range -100/10 mV (hp -80 mV). Spontaneous action potentials were 
recorded from small aggregates of fluorescent cells (2-4 cells/aggregate). Inter-beat interval 
(IBI) is defined as the time from one action potential peak to the next one. The coefficient of 
variation of IBI (CVIBI) was defined as the ratio between IBI and 𝐼𝐵𝐼̅̅ ̅̅ . NRVCs were measured 
at 37±1°C.  
Genetic analysis. 
The investigation conforms to the principles outlined in the Declaration of Helsinki. For 
caveolin-3 gene screening, approval was granted by ethic review board of the University of 
Milan. Written informed consent was obtained from the patients or parents prior to carrying 
out genetic analysis on genomic DNA extracted from whole blood or saliva (Puragene Blood 
Kit, Qiagen). The coding sequence of CAV3 was amplified by PCR using the following 
primers: for exon1, 5’ccaagtattttcagccccag3’ (F) and 5’cctcggcgggcggagagtgt3’ (R); for exon2 
5’gggtggcttctgtgagttga3’ (F) and 5’agaaagaaaagacggcccag (R). The PCR reaction mixture 
included 100 ng of genomic DNA, 1 µmol/L primers and the FastStart Taq DNA Polymerase 
(Roche). Analysis of the amplicons was carried out by DNA sequencing (Bio-Fab Research). 
Computational analysis. 
On the original Grandi-Bers model38 of human atrial cell, we introduced the If current 
formulation from the Koivumaki model39: 
fKfNaf III =  
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with a maximal conductance of 0.8575 S/F. In this way, under voltage clamp simulation, a 
late component was introduced (0,11% of the peak current, as reported by Cronk and 
colleagues31). The intracellular potassium concentration was set to 140 mmol/L and the 
maximal conductance of the IK1 current was slightly increased (8%) in order to restore the 
original resting potential. The T78M condition was implemented after the insertion of the 
effects on the If and IKur current recorded in our experiments in MEF-KO cells and by setting 
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the late INa conductance to 4.0216 S/F (equal to 0.48% of the peak current, as reported by 
Cronk et al.31). The model was paced at 1 Hz until steady state was reached. Since 
computational model of human sinoatrial cell are still not available, we used the Sever-
DiFrancesco model of single sinoatrial node cell. The steady-state INa inactivation slope was 
slightly increased in order to reproduce, under voltage clamp in control conditions, an amount 
of late INa current equal to 0.11% of the peak current. To model the T78M condition, the late 
INa current was added with a maximal conductance of 0.5306 nS (equal to 0.48% of the peak 
current). Effects on If were also implemented as reported above. All numerical simulations 
and data analysis were performed in Matlab (Mathworks, Inc.). 
Statistical analysis. 
Data were compared with nested ANOVA using SPSS Statistics (IBM), setting the type of 
cav-3 (WT, T78M, WT/T78M) as fixed factor and the transfection as nested factor. Since 
transfection did not result in a significant factor on any parameter analyzed, data were 
subsequently compared considering only the type of cav-3 as categorical factor, hence using 
one-way ANOVA followed by Fisher’s post hoc test. Activation and inactivation curves were 
evaluated by comparing the mean V1/2 values derived by the Boltzmann fitting using one-way 
ANOVA followed by Fisher’s test. Significance level was set to p=0.05. 
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RESULTS 
The T78M cav-3 reaches the membrane and does not alter the formation of caveolae. 
To address the cellular localization of the T78M cav-3 variant, we took advantage of cav-3 
proteins fused with eGFP fluorescent proteins. Figure 1 shows live staining of MEF-KO cells 
transfected with either the WT or the T78M cav-3. In addition, we co-transfected fluorescent 
plasmids able to stain the plasma membrane (pm) (see Material and Methods). As clearly 
visible, both the WT (Fig.1, top) and the T78M cav-3 (Fig.1, bottom) reaches the membranes 
(yellow signal).  
 
Figure.  1. T78M cav-3 is localized in the plasma membrane. Representative live staining confocal images of 
MEF-KO cells transfected with either the WT (green, top) or T78M (green, bottom) cav-3. All cells were also 
co-transfected with membrane-targeted CFP plasmid (pm, red, center). Right panels shows signals 
overlapping(yellow). Exp=3; scale bar=20M.  
Despite this result showed the correct plasma membrane localization of the cav-3 variant, it 
was not informative about the proper generation of the caveolar structure. We thus performed 
electron microscopy experiments in order to evaluate the ability of cells expressing the T78M 
variant to proper generate the caveolar structure. We firstly assessed that our cellular system 
completely lacks caveolae as well as caveolins (Fig.2A). We found that in MEF-KO cells 
transfected with either the WT or T78M cav-3 (Fig.2B and 2C, respectively), the caveolae 
(arrows) were properly detected at the plasma membrane. In particular, we found an equal 
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amount of caveolar structure per unit of length in the presence of either the WT or T78M cav-
3, as summarized in the bar graph in Fig.2D. These results suggest that the T78M cav-3 is 
able to reach the membrane without affecting neither caveolae formation nor distribution. 
 
 
Figure.  2. Caveolae formation and distribution is not affected by T78M cav-3. A-C) Representative 
transmission electron micrograph section in non-transfected MEF-KO and MEF-KO transfected with either the 
WT or T78M cav-3 (from left to right, respectively). Arrows indicate caveolae structure at the plasma membrane 
(pm). D) Bar graph of the mean caveolae distribution in WT (black) or T78M (green) transfected MEF-KO cells 
(WT: 0.056± 0.007 cav/mm n= 25, T78M:0.053± 0.006 cav/mm; n=25, from 3 experiments). rer, rough 
endoplasmic reticulum; N, nucleus; G, Golgi apparatus; M ,mitochondrion. Scale bar =150 nm. 
The T78M cav-3 is present in the low-density fractions and binds both hKv1.5 and 
hHCN4.  
We analyzed if the T78M cav-3 is present in the lipid rafts fraction (LR), as previously 
reported for the WT isoform. Moreover, we also checked if hKv1.5 and hHCN4 still resides 
in the lipid rafts fraction. We chose these channels not only because they were shown to bind 
to cav-318,25, but their dysfunction has already been associated with arrhythmias40,41. We firstly 
found that, after the separation of the membrane fractions based on their density using a 
discontinuous sucrose gradient, both the WT and the T78M cav-3, together with both ion 
channels, are present in the LR phase, as visible in the representative blots showed in Figure 
3A. We subsequently checked if both hHCN4 and hKv1.5 were bound by the T78M cav-3. 
The representative blots showed in Figure 3B from co-immunoprecipitation experiments 
demonstrated that, similarly to the WT isoform, the T78M cav-3 is able to bind both channels. 
These results demonstrated that the point mutation did not affect neither the binding with 
both hKv1.5 and hHCN4 channels nor their localization in the LR phase.  
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Figure.  3. T78M cav-3 interacts with both hHCN4 and hKv1.5 and targets them to the lipid raft domain. 
A) Representative blots of hHCN4 (left) and hKv1.5 (right) expressed in MEF-KO transfected with either the 
WT or T78M cav-3 isolated by discontinuous sucrose gradient (n>2; Lys, lysate; LR lipid raft fractions; NLR 
non-lipid raft fractions). B,C) Co-immunoprecipitation (co-IP) experiments from MEF-KO cells co-transfected 
with either HCN4 (B) or V5-Kv1.5 (C) and WT cav-3 EGFP or T78M cav-3 EGFP (n= 3). An aliquot of the 
input (in) and of the co-IP eluate (+) were tested by western blot. A negative control (–) was performed by 
omitting the cav-3 antibody in the IP procedure.  
The T78M cav-3 alters the kinetic properties of hKv1.5 without affecting current 
density.  
After the assessment of the binding between T78M cav-3 and hKv1.5, we analyzed its impact 
on the electric properties of the potassium channel. Thus, we transfected MEF-KO cells with 
either the WT, T78M or both cav-3 isoforms with the hKv1.5, as indicated in the Figure 4.  
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Figure.  4. T78M cav-3 affects kinetic properties of IKv1.5. A) Representative traces of IKv1.5 current elicited 
applying the activation protocol (top) in MEF-KO cells transfected with the WT, T78M or both cav-3 as 
indicated. The insets represent a magnification of the tail currents. B) Representative IKv1.5 traces obtained in 
response to the inactivation protocol (top) in the different conditions as indicated. C) Bar graphs of the mean 
activation (top; V1/2 values (mV): WT 1.41± 0.70, n=27; T78M –2.63± 1.43*, n=23; WT/T78M –2.21± 1.15*, 
n=17), inactivation (center; V1/2 values (mV): WT –5.9± 0.9, n=24; T78M – 10.9± 0.9*, n=24; WT/T78M –
11.5± 0.6*, n=18) and current density-voltage relation (bottom; WT n= 22, T78M n=26, WT/T78M n= 21). 
(f.a., fraction of activation; f.i., fraction of inactivation; WT, black; T78M, green; WT/T78M, blue). *p<0.05 
by nested and One-way ANOVA with Fisher’s test compared to WT cav-3. 
Representative traces of IKv1.5 current elicited in response to the activation (Fig. 4A) or 
inactivation (Fig. 4B) protocol are shown in the WT, T78M or WT/T78M transfected cells 
(top, center and bottom, respectively). As summarized in the mean activation (top) and 
inactivation (center) curves in Figure 4C, we found a significant leftward shift of both in the 
presence of the T78M cav-3. Importantly, the T78M cav-3 behave as a dominant variant, 
since the co-expression with the WT isoform is functionally indistinguishable compared to 
homozygous T78M cav-3. In particular, we found -4.04 and -3.62 mV shifts in the mean 
activation curves in T78M and WT/T78M cav-3 compared to WT cav-3 cells, respectively. 
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Furthermore, the mean inactivation curves of T78M and WT/T78M cav-3 cells compared to 
the WT ones were shifted by -5.00 and -5.60 mV, respectively. In opposition, the current 
density  was not affected (Fig.4 C, bottom). These results suggest that T78M exclusively 
affects the kinetics of the channel inducing a gain-of-function of the IKv1.5 current.  
The T78M cav-3 induces a rightward shift of the activation of hHCN4 channels. 
We also analyzed the impact of the variant on the biophysical properties of the current 
conducted through the hHCN4 channels. In Figure 5A, superimposed normalized traces of 
IHCN4 elicited at -85 mV and followed by a fully activating step at -125 mV are shown. A 
significant rightward shift of the mean activation curves is shown in Figure 5B in the presence 
of the T78M cav-3 in a dominant negative way (+7.90 and +8.80 mV of shift for the T78M 
and WT/T78M cav-3, respectively).  
 
Figure.  5. The T78M cav-3 affects the open probability of hHCN4 channels. A) Representative traces of IHCN4 
currents, normalized and overlapped, were elicited in response to a double-protocol step (-85/-125 mV) from a 
holding potential of -30 mV. Current traces were shown for MEF-KO cells overexpressing the WT (black), T78M 
(green) and WT/T78M (blue) cav-3. B) Mean activation curves (V1/2 values in mV: WT –86.2± 1.1, n=26; T78M 
–78.3± 1.1*, n=30; WT/T78M –77.4± 1.0*, n=29), C) mean  values (WT, n=20; T78M, n=14; WT/T78M, 
n=20) and D) mean current density-voltage plot (WT, n=20; T78M, n=14; WT/T78M, n=20). (f.a., fraction of 
activation) *p<0,05 by nested and One-way ANOVA with Fisher’s test compared to WT cav-3. 
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We did not find modifications of both the kinetics of activation and deactivation (Fig. 5C). 
Similarly, we did not found any modification of the IHCN4 current density (Fig. 5D). Since the 
T78M cav-3 induced a rightward shift of the activation curves for hHCN4, and considering 
that a rightward shift could be induced after the binding of cAMP to the HCN channels, we 
asked if the shift could be addressed by cAMP.  
 
 
 
 
 
 
 
 
After testing saturating concentration of cAMP in the pipette (10 M), we found that the 
rightward shift was present in WT as well as T78M transfected cells (p<0.05). However, it is 
important to notice that the difference after and before cAMP treatment was higher in WT 
compared to T78M cells. These results indicate that T78M cav-3 induces a gain-of-function 
of the current modifying only the kinetic parameters.  
Overall membrane excitability is affected in the presence of the T78M cav-3. 
In order to test the effect of the T78M cav-3 on the overall membrane excitability behind the 
characterization of the single ionic currents, and taking advantage of the dominant negative 
effect of the variant, we also decided to analyze the impact of the T78M cav-3 in the neonatal 
rat ventricular cardiomyocytes (NRVCs). This cellular system express not only the cav-1 and 
cav-3 isoforms, but it also possess most importantly the ionic currents that sustained the 
spontaneous action potential firing.   
  Untreated cAMP (10 µM)  
Cav3 V1/2 (mV)  s (mV)  V1/2 (mV) s (mV) 
WT 
-85,3 ± 1,1 
(n=5) 
9,7 ± 0,2 
(n=5) 
-73,4 ± 1,5§ 
(n=11) 
10,3 ± 0,4 
(n=11) 
T78M 
-77,9 ± 1,2* 
(n=6) 
10,3 ± 0,6 
(n=6) 
-71,9 ± 1,0§ 
(n=16) 
10,8 ± 0,4 
(n=16) 
WT/T78M 
-77,8 ± 1,5* 
(n=8) 
10,0 ± 0,4 
(n=8)  
-72,5 ± 1,5§ 
(n=8) 
9,9  ± 0,6 
(n=8) 
Table 1. V1/2 and inverse slope factor (s) values in MEF-KO transfected with either WT, T78M or both with or 
without saturating concentration of cAMP. *p <0.05 by nested and One-way ANOVA with Fisher’s test 
compared to WT cav-3. § p<0.05 by Student’s T-test compared untreated condition.  
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Figure.  6. Funny current is affected by the T78M cav-3 in cardiomyocytes. A) Normalized and overlapped 
current traces of funny current elicited by -85/-125 mV from a holding potential of -30 mV. B) Mean activation 
curves (V1/2 values in mV: WT –77.51± 1.9, n=9; T78M –70.57± 1.0*, n=9). (f.a., fraction of activation; WT, 
black; T78M, green). *p<0.05 by Student's t-test.  
We firstly tested the effect of T78M on If native current. In Figure 6, the mean activation 
curves of WT vs T78M cav-3 cells showed a significant rightward shift of T78M cav-3 cells, 
similarly to the previous one found in the MEF-KO cells. In Figure 7A, time courses of the 
inter-beat interval (IBI) are shown. It is clear that a more stable action potential firing was 
present in both empty vector (EV) and WT cav-3-transfected cells compared to T78M cav-3 
cells (top, middle and bottom, respectively), as also visible from the representative stretches 
of action potential showed in the insets.  
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Figure.  7. The generation of action potential is compromised in myocytes expressing T78M cav-3. A) Time 
courses of the inter-beat interval (IBI) in neonatal rat ventricular cardiomyocytes (NRVCs) transfected with the 
empty vector (EV, purple), the WT (black) and the T78M (green) cav-3. The insets show 5 seconds representative 
stretches of action potential recorded in the different conditions. Scatter plot showing the single values of B) the 
IBI values (in s: EV 0.55± 0.04, n=7; WT 0.61± 0.04, n=18; T78M 0.58± 0.05, n= 9), C) the coefficient of 
variation of IBI (CVIBI; EV 0.14± 0.04; WT 0.12± 0.01; T78M 0.29*± 0.03), D) the maximum diastolic potential 
(MDP; in mV: EV –57.9± 5.2; WT –52.6± 1.6; T78M –55.1± 2.5) and E) the standard deviation of MDP 
(SDMDP; in mV: EV 0.85± 0.21; WT 1.13± 0.12; T78M 2.41*± 0.35). *p< 0.05 vs. all other conditions by nested 
and one-way ANOVA with Fisher’s test. 
The mean IBIs were summarized in the Figure 7B, and no significant differences were 
detected among the analyzed condition. However, the coefficient of variation of the IBI 
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(CVIBI) is significant higher in the T78M cav-3 NRVCs, as summarized in Figure 7C. We also 
evaluated the maximum diastolic potential (MDP) and, again, we found no significant 
differences in the mean values of this parameter in the three conditions (Fig. 7D), whereas its 
variability is significantly affected in the T78M expressing myocytes (Fig. 7E). These results 
showed that the T78M cav-3 is able to influence the overall stability of the action potential 
firing.  
The T78M cav-3 is found with a high frequency in patients affected by supraventricular 
arrhythmic diseases. 
Since these in vitro results pointed out that T78M cav-3 could induce a pro-arrhythmic 
substrate, we analyzed the frequency of this variant in a cohort of healthy controls, arrhythmic 
patients and stillbirths (these last were negative for mutations in KCNQ1, KCNH2 and SCN5A 
genes). In Table 2, the specific composition of the cohorts is enlisted as well as the number of 
allele carrying the T78M variant. We found a significant higher MAF in patients with atrial 
fibrillation, IST and stillbirths compared to bradycardic patients and healthy controls.  
Pathology Allele count/ number Allele frequency 
Inappropriate Sinus Tachycardia (IST) 4/92* 4.35% 
Atrial Fibrillation (AF) 2/32* 6.25% 
Stillbirth 2/74* 2.7% 
Sinus  Bradycardia 1/222 0.45% 
Unaffected controls 0/418 0% 
General population (ExAC) 367/120800 0.3% 
 
Table 1 Frequencies of the 223C>T substitution   
This data indicates that T78M cav-3 is a predisposing factor in supraventricular arrhythmic 
disorders, even if larger epidemiological studies are necessary.  
In silico analysis of atrial and sinoatrial single cell showed a pro-arrhythmogenic action 
potential profile.  
The above-mentioned in vitro experiments were performed using an overexpression approach 
on heterologous and immature cells; thus, we also tested the effect on the overall membrane 
excitability of the T78M cav-3 using an in silico approach. In particular, we modeled the 
T78M-induced modification of ionic currents in two adult cellular system, single atrial cell 
and rabbit sinoatrial node cell, since we found this variant in a population affected by 
supraventricular arrhythmias (Tab. 2). In single atrial cell, we inserted the modification 
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related to the If and IKur current as well as the previously reported modification on both late 
INa and IK1 currents. Accordingly to the numerical reconstruction shown in Figure 8A, the 
insertion of the reduction of about 75% of IK1 generated an action potential unable to correctly 
repolarize to its resting potential, and thus incompatible with life. For this reason, we checked 
in the MEF-KO system the effect of the T78M cav-3 on IK1 current funding no significant 
reduction of the current density, as summarized in the plot in Figure 8B.  
 
Figure.  8. The T78M cav-3 did not alter the IK1 current density. A) Atrial action potential generated using 
the Grandi-Bers human atrial cell model. B) IK1 current density voltage plot recorded as the Ba2+-sensitive 
current in MEF-KO cells.  
We subsequently modeled the above-mentioned modification but omitting modification of 
IK1. The result is shown in Figure 9A, in which a clear shortening of the Action Potential 
Duration (APD) at the 50% or 90% (APD50 and APD90) appeared as well as a mild 
depolarization of the resting potential and a reduction of the peak potential.  
 
Figure.  9. Mathematical models of both atrial and sinoatrial cells show an arrhythmogenic profile in the 
presence of the T78M cav-3. Action potential generating using A) the Grandi-Bers model of human atrial cell 
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and B) the Severi-DiFrancesco model of rabbit sinoatrial cell. In black the basal condition (WT); in green, after 
the insertion of T78M-dependent alterations.  
The simulation was also carried out using a model of rabbit single sinoatrial cell in which the 
modification of both If and INa late was inserted. The resulting simulation is shown in Figure 
9B. We found an increase of the diastolic depolarization rate that led to an increase in firing 
rate. Mild modification of the other parameters were found (APD90 –6%, Maximum 
Diastolic Potential +1mV, upstroke potential –3mV). 
Taken together, these results reinforce the idea that T78M cav-3, at least at the cellular level, 
is able to induce pro-arrhythmic modifications altering the biophysical properties of the ionic 
currents restricted in the caveolar domain.  
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DISCUSSION 
Arrhythmias, Part 1: in search of ion channel mutation.  
The term arrhythmias refers to any modification from the normal sequence of electrical 
impulses in the heart. This is a life-threatening condition that affects an increasing fraction of 
the population. Accordingly to the American Heart Association guidelines, an arrhythmia 
occurs when: 1) the natural pacemaker of the heart, the sinoatrial node (SAN), develops an 
abnormal rate; 2) another region takes over as pacemaker and 3) the spatiotemporal 
conduction is erratic. Despite the clinical manifestations and etiology of arrhythmias are 
extremely heterogeneous and complex, all these electrical disturbances share a common 
point: the ion channel activity of cardiomyocyte is impaired. Over the past 20 years, 
geneticists, molecular cardiologists, and electrophysiologists have collected a wealth of 
information regarding ion channels42. They found that the phenotype of some patients could 
be explained by the expression of mutated ion channels. The first case was reported by Mark 
Keating in the 199843; it was the first evidence of the link between SCN5A mutations and the 
LQTS, de facto funding the discipline of cardiac channelopathies. Indeed, scientists defined 
cardiac channelopathies any arrhythmic disorders of genetic origin related to improper ionic 
control of the cardiac action potential. This work clearly showed that a single point 
substitution carried by ion channels is able to produce significant modification in the 
electrophysiology of the cell. The paradigm “genetic arrhythmias-ion channel mutations” 
allowed the identification of a plethora of rare mutations clearly associated with several 
arrhythmic syndromes44. These advancements had transformed the clinical approach to the 
diagnosis and treatments of such conditions. However, a new paradigm must be taken in 
consideration.  
Arrhythmias, Part 2: beyond ion channel mutation.  
Beyond the biophysical characteristics of the ion channels, the cellular microenvironment 
affect the ionic currents as well. Among protein interacting with ion channels, caveolin-3 (cav-
3) is a key player in the formation of caveolae in muscle cells. Caveolae are membrane 
domains with peculiar lipoprotein composition that influence, among other things, signal 
transduction processes6. The integrity of the caveolar domain has been associated with the 
correct function of the residing ion channels19,23. Mutations on CAV3 define the family of 
diseases known as caveolinopathies26. The main pathologies associated with CAV3 mutations 
are limb girdle muscular dystrophy 1-C (LGMD), HyperCKemia (HCK), rippling muscle 
disease (RMD), distal myopathy (DM), familial hypertrophic myopathy (FHM), Long-QT 
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syndrome (LQTS) and some cases of sudden infant death syndrome (SIDS)28. In literature, 
the association between cav-3 defects and skeletal muscle disorders are well documented45; 
on contrary, the role of cav-3 variants in a cardiac context is weaker due to the lacking of data 
from a cardiologic point of view. It is important to notice that the caveolinopathies could be 
better define as a continuous spectrum of pathologies since the same mutation could be 
identified in patients affected by different syndromes. This behaviour suggest that the CAV3 
mutation are not causative of the phenotype, but that they could participate in the onset of a 
broad range of pathologies in association with the peculiar genetic and environmental 
background of the patient. The interpretation of the molecular basis for cardiac arrhythmia 
susceptibility is a hot topic in both basic science and clinical management of arrhythmic 
syndromes. The most controversial CAV3 mutation is the T78M. 
Who: the T78M cav-3. A variant or a mutation?    
The T78M cav-3 was previously found in patient affected by RMD, proximal myopathy, 
LQTS, idiopathic hyperCKemia, and SIDS28,30-32. We identify the T78M cav-3 in patients 
affected by inappropriate sinus tachycardia, atrial fibrillation and in case of stillbirth (Tab.2). 
In our small cohort of healthy controls, we never identified the variant. On the contrary, 
Spadafora et al.37reported the T78M cav-3 as a common polymorphism in South Italy. 
Moreover, we did not screened patients affected by LQTS and SIDS since was previously 
reported that the frequency of the T78M cav-3 was similar to that found in healthy controls 
and in the exome sequencing project35,36. These works argued against a causative effect of the 
T78M in the etiology of the pathologies. However, it is important to mention that, for cardiac 
arrhythmias, it is hard to define the healthy control group since, in many cases, the patients 
were asymptomatic until the first event. Despite larger epidemiological analysis will be 
required and the fact that the T78M cav-3 exhibits incomplete penetrance, variable 
expressivity, and phenotypic overlap, our data enlarge the clinical spectrum of diseases 
associated with the T78M cav-3. The absence of a clear genotype-phenotype association 
suggest that the T78M cav-3 is a genetic predisposing factor necessary, but not sufficient, to 
induce the phenotypic spectrum of disorders. Strategies to properly interpret the influence of 
mutations that have divergent effects are required; as stated by Schwartz et al: “The lack of 
functional or biological validation of mutation effects remains the most severe limitation of 
genetic test interpretation in the cardiac channelopathies”44. In such genotyping chaos, we 
need to reconsider the importance of phenotype-guided genetic testing46. We thus decide to 
deepen the molecular characterization of the T78M cav-3, in particular on the functional 
effect of the variant on membrane excitability.  
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Where: the cellular localization of the T78M cav-3.  
The first relevant issue was to check the localization of the T78M cav-3. In literature, the 
localization of the variant seems to be cellular-dependent 32,33. We used a cellular system 
derived from mice lacking the CAV1 gene, the mouse embryonic fibroblast (MEF-KO) cells. 
The clear advantage of this system is the absence of caveolar structures (Fig. 2A), since the 
expression of the cav-3 isoform is restricted to muscular cells. Both the WT and T78M cav-3 
properly reach the plasma membrane (Fig.1). Moreover, the T78M cav-3 still resides in the 
lipid raft domain (Fig.3A). We also found that both hKv1.5 and hHCN4 are able to binding 
the T78M cav-3 and hence reside in the lipid raft domain (Fig. 3B). We analyzed these two 
ion channels since they have been associated with supraventricular arrhythmic disorders47,48 
and were influenced by the proper maintenance of the caveolae integrity, as previously 
demonstrated19,23. However, the plasma membrane localization of the T78M cav-3 did not 
automatically implied the correct generation of the caveolar structure, nor their distribution. 
To address this, we performed electron microscopy experiment that confirm the presence of 
caveolae also in MEF-KO cells transfected with the T78M cav-3 (Fig. 2). Despite more insight 
on the composition and functional integrity of caveolae will be mandatory, it seems that the 
T78M cav-3 does not affect the process of generation of the caveolar domain.  
What and how: the effect of the mutation on the ion channel activity and membrane 
excitability.  
We asked if, in spite of proper membrane localization of the variant and apparent integrity of 
the caveolar domain, the T78M cav-3 could alter membrane excitability. We started 
analyzing the effect of the T78M cav-3 on the properties of IKur. We found that, in agreement 
with the Co-IP experiments, the T78M cav-3 did not alter the IKur current density (Fig. 4C). 
On the other hand, the variant affects the kinetic properties of the channel in a dominant 
negative way (Fig. 4C). In particular, T78M cav-3 induces a significant leftward shift of both 
activation and inactivation curves. These modifications result in a gain-of-function of the IKur 
current, hence a major contribution to the repolarizing phase of the atrial action potential. In 
fact, even if the leftward shift of the inactivation curve indicates lower channel availabilityof, 
and thus a loss-of-function effect, the inactivation process for Kv1.5 channels is an order of 
magnitude slower than the activation one. A gain-of-function behaviour of the IKur was 
previously associated with arrhythmic disorders and it is compatible with the atrial fibrillation 
phenotype41. Similarly, modifications of the kinetic properties were also found after the 
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chemical depletion of cholesterol from the membrane19. The presence of the channels in the 
lipid rafts domains, however, lead us to exclude the shift of the channel from caveolar to non 
caveolar domains in the presence of the T78M variant.  
The T78M variant is also able to induce a rightward shift of the mean activation curve of 
HCN4 channels (in MEF-KO; Fig. 5) and of the funny channels (in NRVCs; Fig. 6). This 
imply that, at the same voltage, a higher amount of current flows through the HCN channels; 
hence, the T78M cav-3 induces a gain-of-function of this current. Again, the effect is exerted 
in a dominant negative way. This modification is compatible with the inappropriate sinus 
tachycardia40, a phenotype in which we identified the variant. Moreover, a gain-of function 
of the If current has been previously associated with atrial fibrillation
48, indicating a major 
susceptibility to trigger an action potential in non-nodal cardiac region. We asked if the 
rightward shift could be determined by a modification of the binding between HCN channels 
and cAMP, a cyclic nucleotide that is able to modify HCN open channel probability. After 
testing saturating concentration of cAMP in the pipette, a similar Vhalf value is found in all 
conditions as a consequence of a significant rightward shift also in the presence of the T78M 
in MEF-KO. This result can depend from one or more of the following reasons: 1) since the 
adenylyl cyclase interacts with and is inhibited by cav-349, in the presence of T78M cav-3 the 
basal concentration of cAMP in the cell could be higher; 2) the hHCN4 channels in MEF-
KO cells cannot reach Vhalf values more positive than around -72 mV and thus, in the presence 
of the T78M cav-3 variant, we are unable to see a shift of the same magnitude as that in the 
presence of WT cav-3. In accordance to the Co-IP experiments, the T78M cav-3 does not 
affect the current density.  
Even if the impact of T78M cav-3 on different channels (IKur, IHCN4, INav1.5 and IKir2.1) was 
demonstrated by us and others, the overall effect of the mutation on the membrane excitability 
is hard to predict. In order to partially overcome this point, we followed a double approach; 
we used NRVCs as an in vitro simplified cellular model of cardiomyocytes and we carried out 
an in silico analysis on atrial and sinoatrial single cells. NRVCs represent a good excitable 
cellular system that possess a spontaneous firing activity40,50, and hence express all the 
underlying ionic currents that trigger action potential firing51-56. We also take advantage of the 
dominant negative effect exerted by T78M cav-3 in the MEF-KO system, since both an 
endogenous cav-3 and cav-1 are detectable in NRVCs57. The main advantage of this system 
is that it allowed us to analyze the impact of the variant not only on endogenous ionic 
currents, but most importantly on all the proteins residing in the caveolae49,58; nevertheless, it 
is not a model that could properly recapitulate neither the sinoatrial node nor the atrial cell. 
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We found that the expression of the T78M cav-3 induce a destabilization of the action 
potential patter (Fig. 7). Even if the average inter-beat interval (IBI) and maximum diastolic 
potential (MDP) were not affected, the variability of these two parameters are clearly higher 
in NRVCs expressing the T78M compared to the WT cav-3. The lack of the homogeneity in 
the cells expressing the variant could represent a substrate that could trigger arrhythmic 
events. Moreover, the T78M cav-3 exerted an effect also in the presence of the cav-1/cav-3 
oligomers, since NRVCs possess both. However, it is important to mention that, accordingly 
to the rightward shift of the IHCN4 and If current showed in the presence of the T78M cav-3, 
the IBI should be higher in NRVCs transfected with the variant. A plausible explanation of 
this discordant result is that in NRVCs the If current density
59 is low compared to nodal 
systems (such as mouse23 or rabbit sinoatrial node60), and hence the impact of this current on 
the overall firing rate could be blunted. This, as well as the absence of IKur, which is expressed 
in mature atrial myocytes, represent a limitation of this cellular system, . As an alternative 
approach to test the impact of the T78M cav-3 on the overall excitability, we carried out in 
silico analysis. We used a mathematical model of a single human atrial cell and of a rabbit 
sinoatrial cell (since human models of sinoatrial node cell are still lacking) since we identified 
the T78M cav-3 in patients affected by supraventricular arrhythmias. We modeled all the 
T78M-induced modifications of the ionic channels except the reduction of the IK1. Indeed, the 
insertion of this modification lead to an action potential profile incompatible with life (Fig. 
8). After testing the impact of the T78M cav-3 on IKir2.1 channel in MEF-KO, we indeed failed 
to detect any reduction, and thus we omitted this modification from the model. In the atrial 
cell, the simulation clearly indicate that the modifications of ionic currents triggered by T78M 
cav-3 produces a shortening of the action potential duration and a depolarization of the resting 
potential. Both effects have been previously associated with atrial fibrillation. Indeed, the 
depolarization of the resting potential makes atrial cells more excitable, and thus more prone 
to develop autorhythmic ectopic foci 61. The shortening of the action potential decreases the 
relative refractory period, thus promoting the insurgence of re-entry cycle in the atrial region41. 
In sinoatrial cell, the main effect after modeling the T78M-associated modification is an 
increase in firing rate, perfectly compatible with the inappropriate sinus tachycardia. The 
main limitation of this approach is that the models represent a single cell, and hence 
consideration concerning the conduction of the electric signals could not be assessed. They 
are deterministic models, able to (and validated for) reproduce the average behavior of the 
cell, with fixed cycle length in the case of spontaneously beating cells. In order to reproduce 
inter-beat variability, more sophisticated, but less validated models including some stochastic 
features should be used. 
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Why? The impact of the study.  
T78M cav-3 is the most common mutation on CAV3 found in a broad spectrum of both 
skeletal and cardiac pathologies. We identified T78M cav-3 as a predisposing factor in a 
cohort of patient affected by supraventricular arrhythmias, thus enlarging the phenotypes 
associated with the T78M cav-3. The electrical phenotypic behavior showed in this and 
previous works describe a clear pro-arrhythmogenic effect of the variant. These data, 
however, were obtained using in vitro and in silico models; thus, more complex analysis (i.e. 
24 hours ECG analysis and cardiac imaging) must be carried out on patients carrying the 
T78M cav-3. Moreover, long-term epidemiological studies in cohorts of caveolinopathy 
patients could shed light on the effect of cav-3 mutations in promoting cardiac electrical 
defects. At date, however, we need to consider that epidemiological studies argued the 
pathogenic role of this mutation since it could be found at a similar frequency also in the 
control population. The etiology of most arrhythmic diseases is complex and multifactorial, 
compromising genetic and environmental factors. Nowadays, pure monogenic diseases in 
cardiology are the exception, and not the general law. The variable penetrance in the genetic 
arrhythmias could be explained considering the hypothesis that genetic factors (genes that 
could modify the inward/outward balance of the current during action potential; i.e. CAV3) 
act as modifier of the myocardial substrate, whereas environmental factors could affect the 
probability and magnitude of arrhythmic-triggered events44. However, sorting out the effects 
of genetic modifiers is challenging. Demonstrating the association of a particular genetic 
variants with the arrhythmic syndrome requires the recruitment of a larger population. But it 
is not sufficient. Without additional genetic studies and functional studies, virtually all the 
variants in the minor-disease susceptibility genes (CAV3, SCN4B, AKAP9, SNTA1 and 
CALM3) are uninterpretable46. Accordingly to the M.J. Ackerman definition, “[…] all these 
genes reside deep within the genetic purgatory, a place where the genetic test-ordering 
physician and patients and their families stuck when a variant of uncertain/unknown 
significance (VUS) has been elucidated”. The VUS definition perfectly fits with the T78M 
cav-3.  
How to reconcile these electrical and genetic data? Despite they appeared conflicting, they 
are not. Together, functional and genetic aspects shed light on the pro-arrhythmogenic 
contribution of the T78M cav-3 instead of its causative effect. It is reasonable to hypotize that 
T78M cav-3 is a genetic predisposing factor. In different cellular models, indeed, T78M cav-
3 is able to trigger modifications of the ionic currents and hence of the action potential profile. 
Nowadays, we have not the proper cellular model to study the real impact of this variant. The 
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better available solution could be the use of cardiomyocytes derived from human induced-
pluripotent stem cells (iPS) from patients and heathy control; in this model, we will be able 
to take into account all the genetic variants that could promote the onset of arrhythmias. At 
the same time, a better definition of the cardiological aspects in cohort of patients with 
mutations on cav-3 is mandatory.  
 
Conclusions.  
The T78M cav-3 variant is correctly located in the plasma membrane together with the 
hHCN4 and hKv1.5 channels. The kinetics properties of both channels are affected by the 
variant as well as overall excitability in spontaneously beating cardiomyocytes and 
mathematical models of atria and sinoatrial cell. The high frequency of the T78M cav-3 in a 
cohort of patient affected by supraventricular arrhythmias compared to our control group and 
ExAC database, together with our functional data, indicate a pro-arrhythmogenic contribute, 
even if not causative, of the T78M cav-3.  
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